Fraxinus Americana 1 X Drops ; Globules ; Granules ; Liquid ; Pellet ; Tablet is a Health Canada–registered human drug (DIN 02233136) held by Seroyal International Inc., containing Fraxinus Americana. Health Canada lists its status as Cancelled Post Market (status date 06 Jul 2009). Nexara Health has matched 9 registrations of Fraxinus Americana across 2 other regulated markets.
Health Canada registration
| DIN | 02233136 |
|---|---|
| Brand name | Fraxinus Americana |
| Active ingredient | Fraxinus Americana |
| Strength | 1 X |
| Dosage form | Drops ; Globules ; Granules ; Liquid ; Pellet ; Tablet |
| Route | Oral |
| Company | Seroyal International Inc. |
| Status | Cancelled Post Market — 06 Jul 2009 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Fraxinus Americana registered in other markets
9 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Fraxinus americana | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Fraxinus americana | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United States | White Ash Pollen | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | White Ash Pollen | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | White Ash Pollen | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | White Ash Pollen | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | White Ash Pollen | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | White Ash Pollen | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | White Ash Pollen | Allermed Laboratories, Inc. | Injection | listed | FDA NDC |
See every manufacturer of Fraxinus Americana worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Fraxinus Americana (DIN 02233136) marketed in Canada?
No. Health Canada lists DIN 02233136 as Cancelled Post Market as of 06 Jul 2009.
Who holds the Canadian licence for this product?
Seroyal International Inc. is the company of record in the Health Canada Drug Product Database.
Is Fraxinus Americana registered outside Canada?
Yes — Nexara Health has matched 9 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02233136, status date 2009-07-06; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02233136, status date 2009-07-06; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02233136, status date 2009-07-06; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.